Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYSpero Therapeutics Receives FDA Orphan Drug Designation for SPR720 for the Treatment of Nontuberculous Mycobacterial (NTM) InfectionPREV STORYLexaGene Provides Corporate Update